Arbutus Biopharma Corporation (ABUS)
Biotechnology · Healthcare · $900M
Intrinsic Value (Consensus)
$18.93
Current Price
$4.57
Margin of Safety
+300%
300% Below Intrinsic Value
Value: $19
Price: $5
Valuation Model Estimates
Current Price: $4.57
DCF (Discounted Cash Flow)
$33.86
Graham Number
Not applicable
—
Earnings Power Value
$10.49
Relative Value (P/E)
$12.44
Dividend Discount Model
Not applicable
—
Consensus Value
$18.93
Model Assumptions
Discount Rate
0.0%
Growth Rate
15.1%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
46
Profitability
10/25
Strength
11/25
Valuation
15/25
Growth
10/25
Financial Health Signals
Strong earnings growth (15% YoY)
Key Financials
- EPS (TTM)
- $0.82
- EPS (Forward)
- $0.95
- Book Value
- —
- P/E Ratio
- —
- Forward P/E
- —
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- N/A
- Earnings Growth
- 15.1%
- Dividend Yield
- 0.0%
- Beta
- 0.59
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
NVAXNOVAVAX INC
$36.38+295.4%
Data last updated: 2026-06-21
Source: Yahoo Finance